With very mild or mild asthma at the time of previous assessment
With at least two sputum cell differential counts \> 1 year before follow-up visit
With stable asthma and asthma medication for at least 4 weeks before baseline assessment and before follow-up visit
Able and willing to consent to study procedures
You may not be if
Conditions that could affect measurements, such as any active chronic or systemic inflammatory disease, not related to the respiratory system.
Subjects with a main diagnosis of eosinophilic granulomatosis with polyangiitis (Churg- Strauss syndrome) or hypereosinophilic syndrome.
Respiratory tract infection in the 4 weeks preceding past assessments and in the 4 weeks preceding follow-up visit.
Asthma exacerbation in the 4 weeks preceding past assessments in the 4 weeks preceding follow-up visit.
Current smokers. Ex-smokers must not have smoked for a minimum of 12 months, and should not have a smoking history ≥10 pack years. Subjects who administer nicotine in other forms (patches, chew tobacco, electronic cigarettes, etc.) will also be excluded from the study;
Concomitant disease or condition which could interfere with the conduct of the study, or for which the treatment might interfere with the conduct of the study, or which would, in the opinion of the investigator, pose an unacceptable risk to the subject in this study, including, but not limited to, cancer, alcoholism, drug dependency or abuse, or psychiatric disease.
Pregnant or lactating women at the time of follow-up visit.
Clareo Health | Follow-up of Mild Eosinophilic Asthma
